hydroxyzine pamoate
- Product NDC
- 53002-6212
- 11-digit product format
- 530026212
- Labeler code
- 53002
- Product ID
- 53002-6212_8ed44aee-e8f7-4c9e-b30a-2d615304832c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydroxyzine pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA087479
- Marketing category
- ANDA
- Marketing start
- 1981-12-14
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| M20215MUFR | HYDROXYZINE PAMOATE | 10246-75-0 | HYDROXYZINE PAMOATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-6212-1 | 53002621201 | 10 CAPSULE in 1 BOTTLE (53002-6212-1) | 10 capsule | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-6212-2 | 53002621202 | 20 CAPSULE in 1 BOTTLE (53002-6212-2) | 20 capsule | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-6212-3 | 53002621203 | 30 CAPSULE in 1 BOTTLE (53002-6212-3) | 30 capsule | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-6212-5 | 53002621205 | 15 CAPSULE in 1 BOTTLE (53002-6212-5) | 15 capsule | 2019-01-01 | 0000-00-00 | No | No | Current |